XSAT:SPERM (Sweden)
Â
Unit (1 Ordinary share & 1 Wrt)
kr
0.06
(-4.14%)
May 27
Business Description
Spermosens AB
ISIN : SE0015346424
Share Class Description:
XSAT:SPERM: Unit (1 Ordinary share & 1 Wrt)Compare
Compare
Traded in other countries / regions
SPERM.Sweden9R5.Germany IPO Date
2021-05-05Description
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | -0.89 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -31.4 | |||||
| 3-Year EPS without NRI Growth Rate | -37.2 | |||||
| 3-Year FCF Growth Rate | -25.3 | |||||
| 3-Year Book Growth Rate | 14.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.82 | |||||
| 9-Day RSI | 24.99 | |||||
| 14-Day RSI | 31.83 | |||||
| 6-1 Month Momentum % | -51.89 | |||||
| 12-1 Month Momentum % | -67.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.43 | |||||
| Quick Ratio | 0.43 | |||||
| Cash Ratio | 0.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.7 | |||||
| Shareholder Yield % | -74.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -42.3 | |||||
| ROA % | -33.78 | |||||
| ROIC % | -32.57 | |||||
| ROC (Joel Greenblatt) % | -1571.24 | |||||
| ROCE % | -36.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.4 | |||||
| EV-to-EBIT | -0.93 | |||||
| EV-to-EBITDA | -0.95 | |||||
| EV-to-FCF | -1.46 | |||||
| Earnings Yield (Greenblatt) % | -107.55 | |||||
| FCF Yield % | -138.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spermosens AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.151 | ||
| Beta | 0 | ||
| Volatility % | 279.48 | ||
| 14-Day RSI | 31.83 | ||
| 14-Day ATR (kr) | 0.029447 | ||
| 20-Day SMA (kr) | 0.131385 | ||
| 12-1 Month Momentum % | -67.6 | ||
| 52-Week Range (kr) | 0.053583 - 0.471516 | ||
| Shares Outstanding (Mil) | 85.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spermosens AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spermosens AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spermosens AB Frequently Asked Questions
What is Spermosens AB(XSAT:SPERM)'s stock price today?
The current price of XSAT:SPERM is kr0.06. The 52 week high of XSAT:SPERM is kr0.47 and 52 week low is kr0.05.
When is next earnings date of Spermosens AB(XSAT:SPERM)?
The next earnings date of Spermosens AB(XSAT:SPERM) is 2024-05-30.
Does Spermosens AB(XSAT:SPERM) pay dividends? If so, how much?
Spermosens AB(XSAT:SPERM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers